TNF and Crohn disease: Although the SEAVUE cohort only included biologic-naïve patients with Crohn’s disease, two of the three studies that made up the testing cohort for the MM-SES-CD included patients who had previously failed tumor necrosis factor (TNF) antagonists,11 suggesting our findings may be applicable to bio-naïve and bio-experienced patients with CD.